American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Divergent population dynamics and gene signaling in monocytes distinctly influence responses to CD19-targeted CAR T-cells in relapsed/refractory B-NHL
    Meeting Abstract

    Blumenberg, V.; Kazerani, M.; Straub, T.; Corrado, F.; Borisov, V.; Baumann, S.; Busch, G.; Wulf, J.; Petrera, A.; Rejeski, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Targeting PERK arm of unfolded protein response helps to eliminate therapy-induced residual senescent-like acute myeloid leukemia cells
    Meeting Abstract

    Poigaialwar, G.; Takao, S.; Chaudhry, S.; Schmalbrock, L. K.; Gupta, V.; Kentsis, A.; Aguirre-Ghiso, J. A.; Konopleva, M.; Sosa, M. S.; Skwarska, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Proteolytic control and therapeutic targeting of oncogenic gene expression in acute myeloid leukemia
    Meeting Abstract

    Uni, M.; Steinberg, A. P.; Slavit, A.; Rha, S.; Cheng, S.; Schmalbrock, L. K.; Su, J.; Ma, J.; McPherson, A.; Mullighan, C. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative analysis of outcomes with HMA plus venetoclax vs intensive chemotherapy in AML patients harboring very-high risk cytogenetics
    Meeting Abstract

    Aguirre, L. E.; Bewersdorf, J. P.; Liu, Y.; Shallis, R. M.; Boussi, L.; Zucenka, A.; Garciaz, S.; Bystrom, R. P.; Deangelo, D. J.; Stone, R. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Validation of dynamic deep learning for the prediction of cancer-associated thrombosis
    Meeting Abstract

    Mantha, S.; Singh, R.; Zwicker, J. I.; Li, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with relapsed or refractory, splicing factor-mutant myeloid malignancies
    Meeting Abstract

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A. T.; Sallman, D.; Patel, M.; Stevens, D. A.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Updated comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy using a matching-adjusted indirect comparison
    Meeting Abstract

    Lopez-Muñoz, N.; Bar, N.; Diels, J.; van Sanden, S.; Mendes, J.; Lee, S.; Hernando, T.; Lendvai, N.; Patel, N.; Ishida, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Developing an optimal fully-human CD371-targeting IL-18 secreting CART cell for the treatment of acute myeloid leukemia
    Meeting Abstract

    Shahid, S.; Mathew, S.; Souness, S.; Burns, E. R.; Um, J. S.; Yoo, S.; Cai, W.; Pohl, M. A.; Fujino, T.; Zhang, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (Ide-cel) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) with an inadequate response to front-line autologous stem cell transplantation (ASCT): KarMMa-2 cohort 2c extended follow-up
    Meeting Abstract

    Paul, B.; Dhodapkar, M. V.; Alsina, M.; Berdeja, J. G.; Richard, S.; Vij, R.; Leleu, X.; Egan, D. N.; Bergsagel, P. L.; Reshef, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Cytokine modulation correlates strongly with symptom improvement in patients with myelofibrosis treated with nuvisertib (TP-3654), an investigational selective PIM1 kinase inhibitor
    Meeting Abstract

    Rein, L. A. M.; El Chaer, F.; Yuda, J.; Shimoda, K.; Rampal, R.; Scandura, J. M.; Takami, A.; McCloskey, J.; Ichii, M.; Shirane, S.; more...
    Blood (2024)

    Fulltext@MSK | Save